Variant report
Variant | nsv528942 |
---|---|
Chromosome Location | chr13:91926396-91933782 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:26)
- CpG islands (count:0)
- Chromatin interactive region (count:7)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
(count:26 , 50 per page) page:
1
No. | Transcrition factor | Chromosome Location | Cell Line | Cell type | Cell Stage | Matched TF binding sites |
---|---|---|---|---|---|---|
1 | ATF1 | chr13:91929555-91929564 | K562 | blood: | n/a | n/a |
2 | CEBPB | chr13:91929941-91930163 | A549 | lung: | n/a | n/a |
3 | CEBPB | chr13:91929898-91930178 | Hela-S3 | cervix: | n/a | n/a |
4 | CEBPB | chr13:91926960-91927121 | H1-hESC | embryonic stem cell: | n/a | n/a |
5 | EP300 | chr13:91929868-91930153 | Hela-S3 | cervix: | n/a | n/a |
6 | EP300 | chr13:91933132-91933328 | SK-N-SH_RA | brain: | n/a | n/a |
7 | FOS | chr13:91933104-91933432 | HUVEC | blood vessel: | n/a | n/a |
8 | FOS | chr13:91933132-91933359 | MCF10A-Er-Src | breast: | n/a | n/a |
9 | GATA2 | chr13:91933078-91933437 | HUVEC | blood vessel: | n/a | n/a |
10 | JUN | chr13:91932077-91932196 | K562 | blood: | n/a | n/a |
11 | JUND | chr13:91927669-91927754 | H1-hESC | embryonic stem cell: | n/a | n/a |
12 | KAP1 | chr13:91929155-91929911 | HEK293 | kidney: | n/a | n/a |
13 | KAP1 | chr13:91929217-91929645 | U2OS | brain: | n/a | n/a |
14 | MAFF | chr13:91929714-91929734 | K562 | blood: | n/a | n/a |
15 | MYC | chr13:91931622-91931684 | MCF10A-Er-Src | breast: | n/a | n/a |
16 | RCOR1 | chr13:91929943-91930025 | K562 | blood: | n/a | n/a |
17 | SETDB1 | chr13:91929050-91929700 | U2OS | brain: | n/a | n/a |
18 | SPI1 | chr13:91931168-91931487 | GM12891 | blood: | n/a | n/a |
19 | SPI1 | chr13:91931211-91931509 | HL-60 | blood: | n/a | n/a |
20 | SPI1 | chr13:91931114-91931581 | HL-60 | blood: | n/a | n/a |
21 | SPI1 | chr13:91931220-91931461 | GM12891 | blood: | n/a | n/a |
22 | SPI1 | chr13:91931217-91931495 | GM12878 | blood: | n/a | n/a |
23 | STAT3 | chr13:91928794-91928815 | MCF10A-Er-Src | breast: | n/a | n/a |
24 | STAT5A | chr13:91928415-91928685 | K562 | blood: | n/a | n/a |
25 | STAT5A | chr13:91929356-91929700 | K562 | blood: | n/a | n/a |
26 | ZNF143 | chr13:91929327-91929483 | K562 | blood: | n/a | n/a |
No data |
(count:7 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr13:91925141..91926694-chr13:92150177..92152506,2 | K562 | blood: | |
2 | chr13:91922489..91928853-chr13:91929417..91934604,6 | K562 | blood: | |
3 | chr13:91926747..91928257-chr13:92010434..92012597,2 | K562 | blood: | |
4 | chr13:91925284..91927675-chr13:92003883..92005533,2 | K562 | blood: | |
5 | chr13:91931913..91934676-chr13:91949979..91951646,2 | K562 | blood: | |
6 | chr13:91925469..91927024-chr13:91999813..92001365,2 | K562 | blood: | |
7 | chr13:91927540..91929764-chr13:91999146..92002418,3 | K562 | blood: |
No data |
No data |
No data |
Variant related genes | Relation type |
---|---|
PPIAP23 | TF binding region |
ENSG00000214178 | chromatin interactions |
ENSG00000215417 | chromatin interactions |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs1330066 | chr13:91926396-91926397 | Weak transcription | Chromatin interactive region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
2 | rs78865222 | chr13:91926431-91926432 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
3 | rs35998026 | chr13:91926460-91926461 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
4 | rs536767038 | chr13:91926540-91926541 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
5 | rs114535053 | chr13:91926547-91926548 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
6 | rs189283437 | chr13:91926564-91926565 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
7 | rs9583906 | chr13:91926582-91926583 | Weak transcription | Chromatin interactive region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
8 | rs552138805 | chr13:91926584-91926585 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
9 | rs558961454 | chr13:91926588-91926589 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
10 | rs562930259 | chr13:91926606-91926607 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
11 | rs182026228 | chr13:91926635-91926636 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
12 | rs77548476 | chr13:91926641-91926642 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
13 | rs114392064 | chr13:91926688-91926689 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
14 | rs144515385 | chr13:91926745-91926746 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
15 | rs76306973 | chr13:91926748-91926749 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
16 | rs75406605 | chr13:91926775-91926776 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
17 | rs114978355 | chr13:91926779-91926780 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
18 | rs148430646 | chr13:91926786-91926787 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
19 | rs528867637 | chr13:91926787-91926788 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
20 | rs149832145 | chr13:91926794-91926795 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
21 | rs183491125 | chr13:91926798-91926799 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
22 | rs141668453 | chr13:91926830-91926831 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
23 | rs544591391 | chr13:91926838-91926839 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
24 | rs561275217 | chr13:91926861-91926862 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
25 | rs548745096 | chr13:91926863-91926864 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
26 | rs546775453 | chr13:91926870-91926871 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
27 | rs566982588 | chr13:91926955-91926956 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
28 | rs532578929 | chr13:91926956-91926957 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
29 | rs147197544 | chr13:91927011-91927012 | Weak transcription | TF binding regionChromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
30 | rs531884898 | chr13:91927031-91927032 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
31 | rs113408426 | chr13:91927034-91927035 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
32 | rs189238422 | chr13:91927048-91927049 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
33 | rs548881244 | chr13:91927065-91927066 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
34 | rs181179514 | chr13:91927069-91927070 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
35 | rs566235928 | chr13:91927114-91927115 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
36 | rs556499543 | chr13:91927117-91927118 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
37 | rs376516166 | chr13:91927135-91927136 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs371579929 | chr13:91927161-91927162 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs186266525 | chr13:91927162-91927163 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs140493326 | chr13:91927173-91927174 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs552774187 | chr13:91927232-91927233 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs572928858 | chr13:91927240-91927241 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs116587375 | chr13:91927241-91927242 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs191571093 | chr13:91927254-91927255 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs575565107 | chr13:91927255-91927256 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs544507714 | chr13:91927258-91927259 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs79738477 | chr13:91927275-91927276 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs534398529 | chr13:91927309-91927310 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs559489060 | chr13:91927323-91927324 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs181579106 | chr13:91927431-91927432 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
HIV/AIDS | 22032296 | CNVD |
Prostate cancer | 16705090 | CNVD |
High-proliferative meningiomas | 17937814 | CNVD |
Cancer | 20164919 | CNVD |
Autism | 22495311 | CNVD |
Chordoma | 21602918 | CNVD |
Bladder cancer | 21949216 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Burkitt''s lymphoma | 18698080 | CNVD |
Cancer | 21637783 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Chronic lymphocytic leukemia | 21518781 | CNVD |
colon cancer | 17210682 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 21264507 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Ovarian cancer | 20844748 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Intracranial aneurysm | 19064780 | CNVD |
Breast cancer | 19287154 | CNVD |
Acute myeloid leukemia | 18379011 | CNVD |
Human rectal carcinomas | 16397240 | CNVD |
Olfactory neuroblastoma | 18408657 | CNVD |
Multiple myeloma | 17077331 | CNVD |
Ependymoma | 16718352 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Colorectal cancer | 16272173 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Breast cancer | 16608533 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Ovarian cancer | 22174824 | CNVD |
Myoepithelioma | 18604193 | CNVD |
Breast cancer | 17133270 | CNVD |
Prostate cancer | 18632612 | CNVD |
Small bowel adenocarcinoma | 21586687 | CNVD |
Melanoma | 18172304 | CNVD |
Prostate cancer | 16573809 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Non-syndromic sensorineural hearing loss | 18496225 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Gastric cancer | 17908304 | CNVD |
Splenic marginal zone lymphoma | 18492102 | CNVD |
Liposarcoma | 21253554 | CNVD |
Acute promyelocytic leukemia | 19109227 | CNVD |
Chronic lymphocytic leukemia | 20421269 | CNVD |
Acute lymphoblastic leukemia | 21980252 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Lung cancer | 18438408 | CNVD |
Non-syndromic sensorineural hearing loss | 20606397 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Prostate cancer | 21965145 | CNVD |
Gastrointestinal stromal cancer | 20818650 | CNVD |
Cancer | 21220470 | CNVD |
Cancer | 21183584 | CNVD |
Omodysplasia | 19481194 | CNVD |
Breast cancer | 22032731 | CNVD |
Mantle cell lymphoma | 19690137 | CNVD |
Rhabdomyosarcoma | 17210683 | CNVD |
Ovarian clear cell carcinoma | 21343371 | CNVD |
Breast cancer | 21364760 | CNVD |
Medulloblastoma | 19270706 | CNVD |
Myelofibrosis | 22110671 | CNVD |
coloboma | 21285886 | CNVD |
Cancer | 20164920 | CNVD |
Burkitt''s lymphoma | 19759907 | CNVD |
Wilms tumour | 21544195 | CNVD |
Acute myeloid leukemia | 19651601 | CNVD |
Effusion lymphoma | 18079361 | CNVD |
Developmental delay | 21147756 | CNVD |
Breast cancer | 22522925 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr13:91924200-91931200 | Weak transcription | Dnd41 | blood |
2 | chr13:91930800-91934000 | Enhancers | Primary hematopoietic stem cells G-CSF-mobilized Male | -- |
3 | chr13:91930800-91936800 | Enhancers | Primary hematopoietic stem cells G-CSF-mobilized Female | -- |
4 | chr13:91931000-91931200 | Flanking Active TSS | Primary hematopoietic stem cells short term culture | blood |
5 | chr13:91931000-91932000 | Enhancers | Monocytes-CD14+_RO01746 | blood |
6 | chr13:91931200-91932000 | Enhancers | Dnd41 | blood |
7 | chr13:91931200-91932600 | Enhancers | Primary hematopoietic stem cells short term culture | blood |
8 | chr13:91931400-91931800 | Enhancers | Primary monocytes fromperipheralblood | blood |
9 | chr13:91931400-91931800 | Enhancers | Primary hematopoietic stem cells | blood |
10 | chr13:91932600-91933000 | Weak transcription | Primary hematopoietic stem cells short term culture | blood |
11 | chr13:91932800-91933800 | Enhancers | HUVEC | blood vessel |
12 | chr13:91933000-91933200 | Enhancers | Primary hematopoietic stem cells short term culture | blood |
13 | chr13:91933200-91934800 | Weak transcription | Primary hematopoietic stem cells short term culture | blood |